У нас вы можете посмотреть бесплатно Mold and Mycotoxin Illness или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
The challenge of Mold exposure and Mycotoxin illness is another rabbit hole we dive into discussing diagnosis, management, and controversy. *Key Points* #### *Belief in Mycotoxin Illness* Initially skeptical, both speakers now believe in the detrimental effects of mold and mycotoxins due to patient histories, such as symptoms improving after leaving mold-exposed environments. Healthy individuals detoxify mold toxins effectively through liver pathways, but chronically ill patients struggle due to overwhelmed systems. --- #### *Routes of Exposure* Mold exposure occurs through: *Inhalation* of fungal spores. *Ingestion* of contaminated food. Environmental exposure (e.g., water-damaged buildings or hidden mold). --- #### *Why Some Are Affected* Chronically ill patients often have impaired detoxification pathways, leading to toxin buildup. Those with immune dysfunction (e.g., mast cell activation syndrome or autoimmunity) are more vulnerable to mold-related illness. --- *Symptoms* Symptoms are predominantly neurological and neuropsychiatric: Cognitive impairment (brain fog). Emotional instability (anhedonia, dissociation). Dizziness, nausea, headaches. Mycotoxin exposure can worsen underlying conditions like mast cell activation syndrome or inflammatory bowel diseases. --- *Testing for Mycotoxins* Urine testing for specific toxins is commonly used but has reliability issues across labs (e.g., RealTime Labs, Great Plains/Mosaic, Vibrant). Antibody testing for mycotoxins in blood is another method, though controversial. Clinical history remains crucial for diagnosis when symptoms improve after leaving mold-exposed environments. --- *Treatment Approaches* 1. **Environmental Changes**: Removing triggers (e.g., mold remediation or moving away) is critical but expensive and logistically challenging. 2. **Medical Treatments**: **Binders**: Substances like charcoal or cholestyramine prevent toxin reabsorption in the liver-biliary tract. **Detox Support**: Glutathione (IV or liposomal), N-acetylcysteine (NAC), milk thistle, and glycine-NAC combinations support liver detoxification pathways. **Peptides**: VIP spray, Selank, and Semax reduce neuroinflammation and improve symptoms. **Antifungal Medications**: Fluconazole or itraconazole for suspected small intestine fungal overgrowth (SIFO). Enhanced mast cell activation syndrome treatment is often necessary. 3. **Genetic Testing**: Genetic panels (e.g., IntellxxDNA) provide insights into detoxification pathway polymorphisms for personalized treatment strategies. --- *Challenges* Lack of definitive testing methods makes diagnosis difficult. Research on mold-related illnesses remains inconclusive, complicating legal battles over remediation costs. Trial-and-error approaches are often necessary to identify effective treatments. --- *Conclusion* Mold-related illnesses are complex due to diagnostic limitations and multifaceted symptoms. Personalized care based on clinical history, environmental assessment, and detoxification support is essential. Collaboration with experts in mold illness could enhance understanding and treatment strategies.